Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
18.6M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
1.69M
-
Shares change
-
+891K
-
Total reported value, excl. options
-
$3.54M
-
Value change
-
+$1.99M
-
Number of buys
-
10
-
Number of sells
-
-4
-
Price
-
$2.10
Significant Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q1 2023
16 filings reported holding UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share as of Q1 2023.
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.69M shares
of 18.6M outstanding shares and own 9.08% of the company stock.
Largest 10 shareholders include Balyasny Asset Management L.P. (717K shares), Nantahala Capital Management, LLC (647K shares), VANGUARD GROUP INC (115K shares), GEODE CAPITAL MANAGEMENT, LLC (95.9K shares), STATE STREET CORP (35K shares), CAPTRUST FINANCIAL ADVISORS (18.8K shares), TANDEM CAPITAL MANAGEMENT CORP /ADV (15.5K shares), TWO SIGMA ADVISERS, LP (14.6K shares), Oxbow Advisors, LLC (11.9K shares), and Squarepoint Ops LLC (11.5K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.